Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer
Titel:
Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer
Auteur:
Poveda, A. del Campo, J.M. Ray-Coquard, I. Alexandre, J. Provansal, M. Guerra Alía, E.M. Casado, A. Gonzalez-Martin, A. Fernández, C. Rodriguez, I. Soto, A. Kahatt, C. Fernández Teruel, C. Galmarini, C.M. Pérez de la Haza, A. Bohan, P. Berton-Rigaud, D.